![Thomas Ulmer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Thomas Ulmer
Financieel Directeur/CFO bij
PYC THERAPEUTICS LIMITED
Profiel
Thomas Ulmer is currently Non-Executive Director at Aravax Pty Ltd. since 2020 and Chief Financial Officer at PYC Therapeutics Ltd. starting in 2026.
Formerly, Mr. Ulmer was Co-Managing Director at Immatics Biotechnologies GmbH from 2018 to 2020, Head-Planning, Forecasting & Resource Allocation at Merck KGaA from 2012 to 2016, Chief Financial Officer at Immatics NV, and Chief Financial Officer at Cell Therapies Pty Ltd. Education includes an MBA from the University of Giessen.
Actieve functies van Thomas Ulmer
| Bedrijven | Functie | Begin |
|---|---|---|
| PYC THERAPEUTICS LIMITED | Financieel Directeur/CFO | 07-07-2026 |
Aravax Pty Ltd.
 Aravax Pty Ltd. BiotechnologyHealth Technology Develops treatments for peanut allergies | Directeur/Bestuurslid | 01-11-2020 |
Eerdere bekende functies van Thomas Ulmer
| Bedrijven | Functie | Einde |
|---|---|---|
Immatics Biotechnologies GmbH
 Immatics Biotechnologies GmbH BiotechnologyHealth Technology Operates as a bio technology company that develops and delivers T cell redirecting immunotherapies for treatment of cancer | Algemeen Directeur | 12-02-2020 |
| MERCK KGAA | Corporate Officer/Principal | 01-07-2016 |
Cell Therapies Pty Ltd. | Financieel Directeur/CFO | - |
| IMMATICS N.V. | Financieel Directeur/CFO | - |
Opleiding van Thomas Ulmer
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
61
Eerstegraads connecties
7
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 7 |
|---|---|
Merck KGaA
 Merck KGaA Pharmaceuticals: MajorHealth Technology Engages in the manufacturing of pharmaceutical and chemical products | Health Technology |
PYC Therapeutics Ltd.
 PYC Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides discovery and development of peptide based therapeutic candidates | Health Technology |
Immatics Biotechnologies GmbH
Immatics Biotechnologies GmbH BiotechnologyHealth Technology Operates as a bio technology company that develops and delivers T cell redirecting immunotherapies for treatment of cancer | Health Technology |
University of Giessen
 University of Giessen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cell Therapies Pty Ltd. | |
Aravax Pty Ltd.
Aravax Pty Ltd. BiotechnologyHealth Technology Develops treatments for peanut allergies | Health Technology |
Immatics NV
 Immatics NV Pharmaceuticals: MajorHealth Technology Engages in developing immunotherapies for cancer treatments | Health Technology |
